Understanding which hospitalized patients with cirrhosis face the highest risk of mortality is a pressing challenge in modern healthcare. Years of research and development have culminated in an AI model designed to accurately predict mortality risk for these patients, significantly aiding
In the rapidly evolving field of cancer epidemiology, understanding how race and ethnicity interact with cancer incidence and mortality is crucial. Ivan Kairatov, a biopharma expert with a strong background in research and development, sheds light on the implications of changing race data
India's healthcare landscape is experiencing transformative changes with recent advancements, including the inauguration of the Phenome India "National Biobank." This ambitious initiative, spearheaded by Dr. Jitendra Singh, underscores a pivotal moment for personalized healthcare in the country.
In the evolving landscape of healthcare, seamless integration between payers and providers is not just a trend but a necessity for enhancing patient care and provider engagement. Fragmented and isolated data have long been challenges that hinder timely and informed decision-making in the medical
The evolution of statistical methodologies within the realm of randomized controlled trials (RCTs) conducted by the Oxford Clinical Trials Research Unit (OCTRU) highlights significant transitions and adaptations over recent years. OCTRU, in its commitment to conducting rigorous and methodologically
The pharmaceutical and medical technology sectors have long grappled with the complexities of clinical trial management. Traditionally, these processes involved disparate systems and manual workflows, leading to inefficiencies, data silos, and delays. However, the advent of electronic quality
